All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@onehottrail's finasteride testosterone claim fact-checked

OneHot

Instagram creator

39.6K viewsView on Instagram→

Quick answer

The subject has a total testosterone of 893 ng/dL, placing him well above average for his age group, with free testosterone at 13.03 ng/dL (1.46% of total) and SHBG at the upper limit of the normal reference range. This pattern is consistent with SHBG-mediated reduction in bioavailable testosterone rather than HPG axis suppression from finasteride. Whether intervention is warranted depends on symptoms and a full clinical evaluation, not a single blood draw.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @onehottrail actually say?

The creator reviewed blood work for someone who used finasteride for two years, concerned it had damaged his testosterone levels. The numbers: total testosterone at 893 ng/dL, free testosterone at 13.03 ng/dL (roughly 1.46% of total), SHBG at the upper end of normal, and estradiol described as borderline high. The creator's conclusion was that elevated SHBG and increased aromatase activity are suppressing free testosterone, and that "with some fine tuning he could definitely see some improvements." They also speculated that oxidative stress or natural aromatase variation could explain the pattern, and compared the subject's levels to their own experience on 2.5 mg finasteride daily.

The framing is measured. They explicitly say the levels "are not bad whatsoever" and avoid catastrophizing. That restraint matters here, because the headline asks whether finasteride "ruined" his testosterone, and the actual answer delivered is: probably not.

Does the science back this up?

Mostly, yes, with some important caveats. The SHBG-free testosterone relationship is real and well-documented. Higher SHBG binds more testosterone, leaving less bioavailable. The creator's logic there is sound.

On aromatase, they're in the right neighborhood but slightly off on mechanism language (more on that below). Finasteride does not consistently raise estradiol in clinical studies. A 2003 paper by Gormley et al. in the Journal of Urology and a 2010 Cochrane review by Tacklind et al. both found no clinically significant increase in estradiol with 1 mg or 5 mg finasteride use. Some individual variation exists, but the creator's claim that finasteride is "known to increase estradiol levels" overstates the evidence. What finasteride does do is shift the androgen ratio by blocking 5-alpha reductase, which reduces DHT and can theoretically push more testosterone toward aromatization, but this effect is modest and inconsistent across populations.

The "2% free testosterone" benchmark the creator references is a rough clinical heuristic, not a validated physiological target. Reference ranges vary by lab and assay method.

What did they get wrong (or right)?

They got the big picture right: a total testosterone of 893 ng/dL with free testosterone around 13 ng/dL and elevated SHBG is a coherent clinical picture, and the explanation they offer, that SHBG is reducing bioavailable testosterone while aromatase converts some of the remainder to estradiol, is a reasonable interpretation.

The errors are in the details. First, they repeatedly say "rheumatase" when they mean aromatase (the enzyme encoded by CYP19A1). This is either a consistent mispronunciation or a misunderstanding of the enzyme name. Either way, it will confuse viewers. Second, the claim that finasteride is "known to increase estradiol" is not supported by the weight of clinical evidence. It's a plausible mechanism on paper, but studies don't reliably confirm it. Third, the oxidative stress speculation as a cause of low free testosterone at blood draw is not well-supported by evidence and comes across as filler rather than informed analysis. Oxidative stress does not acutely suppress SHBG or free testosterone in any documented, clinically meaningful way at that time scale.

Credit where it's due: they appropriately call for a more comprehensive panel rather than jumping to interventions. That's the right call.

What should you actually know?

If you're on finasteride and worried about testosterone, the evidence is reassuring for most people. A 2019 systematic review by Mella et al. in the Journal of the American Academy of Dermatology found no statistically significant change in total testosterone with finasteride use at standard doses. Free testosterone data is thinner, but the existing studies don't point to a consistent suppressive effect.

SHBG elevation is common and influenced by many factors including thyroid function, liver health, alcohol intake, body composition, and age. If your free testosterone looks low relative to your total, SHBG is the first place to look, and lifestyle factors often move it more than any drug. If SHBG is consistently elevated and symptomatic, that's a conversation for a clinician, not an Instagram comment section.

Estradiol management is genuinely nuanced. High estradiol in men is associated with symptoms, but so is estradiol that's too low. Suppressing it without clinical guidance is not a neutral intervention. Anyone considering an aromatase inhibitor based on a video like this should think carefully before acting on that.

Should you worry about finasteride and testosterone?

For most men at standard doses, the evidence says no. The post-finasteride syndrome debate is real and ongoing, but it is distinct from the question of whether finasteride measurably suppresses testosterone. The data on testosterone levels specifically does not support the panic framing in the caption. The creator's own conclusion, buried under the dramatic headline, is that this person's testosterone is above the 90th percentile and "not bad whatsoever." That's the actual story here, and it deserves more prominence than the alarming setup gives it.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @onehottrail's finasteride testosterone claim fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@onehottrail's finasteride testosterone claim fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

The subject has a total testosterone of 893 ng/dL, placing him well above average for his age group, with free testosterone at 13.

FormBlends verdict

The subject has a total testosterone of 893 ng/dL, placing him well above average for his age group, with free testosterone at 13.03 ng/dL (1.46% of total) and SHBG at the upper limit of the normal reference range. This pattern is consistent with SHBG-mediated reduction in bioavailable testosterone rather than HPG axis suppression from finasteride. Whether intervention is warranted depends on symptoms and a full clinical evaluation, not a single blood draw.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The subject has a total testosterone of 893 ng/dL, placing him well above average for his age group, with free testosterone at 13.03 ng/dL (1.46% of total) and SHBG at the upper limit of the normal reference range. This pattern is consistent with SHBG-mediated reduction in bioavailable testosterone rather than HPG axis suppression from finasteride. Whether intervention is warranted depends on symptoms and a full clinical evaluation, not a single blood draw.
  • A 2019 systematic review by Mella et al. in JAAD found no statistically significant change in total testosterone with finasteride use at standard therapeutic doses.
  • Total testosterone of 893 ng/dL is above the 90th percentile for men aged 20-44 based on population reference data, suggesting the HPG axis is functioning normally.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • A 2019 systematic review by Mella et al. in JAAD found no statistically significant change in total testosterone with finasteride use at standard therapeutic doses.
  • Total testosterone of 893 ng/dL is above the 90th percentile for men aged 20-44 based on population reference data, suggesting the HPG axis is functioning normally.
  • SHBG is the primary driver of low free testosterone relative to total testosterone, and it is influenced by thyroid status, liver function, alcohol use, and body composition, not just medications.
  • The creator repeatedly says 'rheumatase' but means aromatase (CYP19A1), the enzyme that converts testosterone to estradiol. This is either a mispronunciation or a factual error.
  • The claim that finasteride consistently raises estradiol is not supported by the weight of randomized controlled trial evidence; a 2010 Cochrane review found no clinically significant estradiol increase.
  • Free testosterone reference ranges vary by assay and lab, and the '2% of total' benchmark the creator uses is a rough heuristic, not an evidence-based clinical standard.
  • Anyone considering aromatase inhibitors or SHBG-lowering interventions based on a single blood panel should consult a clinician, since both over- and under-correction of estradiol carry documented risks.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

OneHot · Instagram creator

39.6K views on this video

Did finasteride ruin his testosterone levels? — #lastofthenattys #testosterone #testosteronebooster #naturaltestosterone #testosteronelevels #testosteroneboost #lowtestosterone #testosteroneoptimiz

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by OneHot, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.